Thomas P Burris

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

ACS chemical biology

ACS pharmacology & translational science

Journal of medicinal chemistry

Nature communications

Florida State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Florida State University

United States

PHD :: Molecular Biophysics

Publications

Joshua M Nicholson, Dexi Yang, Thomas Koelblen, Eric L Hu, Christopher C Coss, Thomas P Burris, Xiao Hu, Glenn C Micalizio
Merging Natural Product Structures with Pharmaceutical Leads: Unnatural Enantiomers of Estranes as Glucocorticoid Receptor Modulators That Suppress TNF-α and IL-6 Release. Journal of medicinal chemistry (2024)
Lauren E Markham, Thomas Koelblen, Harry R Chobanian, Ariele Viacava Follis, Thomas P Burris, Glenn C Micalizio
From Functional Fatty Acids to Potent and Selective Natural-Product-Inspired Mimetics via Conformational Profiling. ACS central science 10 (2) (2024)
Lauren E Markham, Thomas Koelblen, Harry R Chobanian, Ariele Viacava Follis, Thomas P Burris, Glenn C Micalizio
From Functional Fatty Acids to Potent and Selective Natural-Product-Inspired Mimetics via Conformational Profiling. ACS central science 10 (2) (2024)
Cyrielle Billon, Sadichha Sitaula, Subhashis Banerjee, Ryan Welch, Bahaa El-Dien M El-Gendy, Lamees Hegazy, Tae Gyu Oh, Melissa Kazantzis, Arindam Chatterjee, John Chrivia, Matthew E Hayes, Weiyi Xu, Angelica Hamilton, Janice M Huss, Lilei Zhang, John K Walker, Michael Downes, Ronald M Evans, Thomas P Burris
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity. ACS chemical biology (2023)
HtooTint Wai, Thomas Koelblen, Matthew E Hayes, Thomas P Burris, Glenn C Micalizio
Progress toward the De Novo Asymmetric Synthesis of Euphanes. Organic letters 24 (20) (2022)
Kristine Griffett, Matthew Hayes, Gonzalo Bedia-Diaz, Kevin Appourchaux, Ryan Sanders, Michael P Boeckman, Thomas Koelblen, Jinsong Zhang, Ira G Schulman, Bahaa El-Dien M El-Gendy, Thomas P Burris
Antihyperlipidemic Activity of Gut-Restricted LXR Inverse Agonists. ACS chemical biology 17 (5) (2022)
Meghan H Murray, Aurore Cecile Valfort, Thomas Koelblen, Céline Ronin, Fabrice Ciesielski, Arindam Chatterjee, Giri Babu Veerakanellore, Bahaa El-Dien M El-Gendy, John K Walker, Lamees Hegazy, Thomas P Burris
Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB. Nature communications 13 (1) (2022)
Manasi Malik, Michael D Ward, Yingye Fang, Justin R Porter, Maxwell I Zimmerman, Thomas Koelblen, Michelle Roh, Antonina I Frolova, Thomas P Burris, Gregory R Bowman, Princess I Imoukhuede, Sarah K England
Naturally Occurring Genetic Variants in the Oxytocin Receptor Alter Receptor Signaling Profiles. ACS pharmacology & translational science 4 (5) (2021)
Myrthala Moreno-Smith, Giorgio Milazzo, Ling Tao, Baharan Fekry, Bokai Zhu, Mahmoud A Mohammad, Simone Di Giacomo, Roshan Borkar, Karthik Reddy Kami Reddy, Mario Capasso, Sanjeev A Vasudevan, Pavel Sumazin, John Hicks, Nagireddy Putluri, Giovanni Perini, Kristin L Eckel-Mahan, Thomas P Burris, Eveline Barbieri
Restoration of the molecular clock is tumor suppressive in neuroblastoma. Nature communications 12 (1) (2021)
Thomas P Burris
Clock regulation of protein secretion. Nature cell biology 22 (1) (2020)
Emmalie Schoepke, Cyrielle Billon, Keith M Haynes, Amer Avdagic, Sadichha Sitaula, Ryan Sanders, Christiana M Adeyemi, John K Walker, Thomas P Burris
A Selective ERRα/γ Inverse Agonist, SLU-PP-1072, Inhibits the Warburg Effect and Induces Apoptosis in Prostate Cancer Cells. ACS chemical biology 15 (9) (2020)
Qianli Wang, Michelle L Robinette, Cyrielle Billon, Patrick L Collins, Jennifer K Bando, José Luís Fachi, Cristiane Sécca da Silva, Sofia I Porter, Ankita Saini, Susan Gilfillan, Laura A Solt, Erik S Musiek, Eugene M Oltz, Thomas P Burris, Marco Colonna
Circadian rhythm-dependent and circadian rhythm-independent impacts of the molecular clock on type 3 innate lymphoid cells. Science immunology 4 (40) (2020)
Deborah A Roby, Fernanda Ruiz, Bailey A Kermath, Jaymie R Voorhees, Michael Niehoff, Jinsong Zhang, John E Morley, Erik S Musiek, Susan A Farr, Thomas P Burris
Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer's disease. PloS one 14 (4) (2019)
Monideepa Sengupta, Kristine Griffett, Colin A Flaveny, Thomas P Burris
Inhibition of Hepatotoxicity by a LXR Inverse Agonist in a Model of Alcoholic Liver Disease. ACS pharmacology & translational science 1 (1) (2018)
Bahaa El-Dien M El-Gendy, Shaimaa S Goher, Lamees S Hegazy, Mohamed M H Arief, Thomas P Burris
Recent Advances in the Medicinal Chemistry of Liver X Receptors. Journal of medicinal chemistry 61 (24) (2018)

Thomas P Burris.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas P Burris